These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29172946)

  • 1. Postprandial gut microbiota-driven choline metabolism links dietary cues to adipose tissue dysfunction.
    Schugar RC; Willard B; Wang Z; Brown JM
    Adipocyte; 2018 Jan; 7(1):49-56. PubMed ID: 29172946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolism.
    Pathak P; Helsley RN; Brown AL; Buffa JA; Choucair I; Nemet I; Gogonea CB; Gogonea V; Wang Z; Garcia-Garcia JC; Cai L; Temel R; Sangwan N; Hazen SL; Brown JM
    Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1474-H1486. PubMed ID: 32330092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trigonelline inhibits intestinal microbial metabolism of choline and its associated cardiovascular risk.
    Anwar S; Bhandari U; Panda BP; Dubey K; Khan W; Ahmad S
    J Pharm Biomed Anal; 2018 Sep; 159():100-112. PubMed ID: 29980011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Gut Microbial Endocrine Organ in Type 2 Diabetes.
    Massey W; Brown JM
    Endocrinology; 2021 Feb; 162(2):. PubMed ID: 33373432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Microbiome in Heart Failure.
    Kitai T; Kirsop J; Tang WH
    Curr Heart Fail Rep; 2016 Apr; 13(2):103-9. PubMed ID: 26886380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiota and Cardiovascular Disease.
    Witkowski M; Weeks TL; Hazen SL
    Circ Res; 2020 Jul; 127(4):553-570. PubMed ID: 32762536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gut microbiome, diet, and links to cardiometabolic and chronic disorders.
    Aron-Wisnewsky J; Clément K
    Nat Rev Nephrol; 2016 Mar; 12(3):169-81. PubMed ID: 26616538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiome, trimethylamine N-oxide, and cardiometabolic disease.
    Tang WH; Hazen SL
    Transl Res; 2017 Jan; 179():108-115. PubMed ID: 27490453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer.
    Oellgaard J; Winther SA; Hansen TS; Rossing P; von Scholten BJ
    Curr Pharm Des; 2017; 23(25):3699-3712. PubMed ID: 28641532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the relationship between the gut microbiota and amino acid metabolism.
    Lin R; Liu W; Piao M; Zhu H
    Amino Acids; 2017 Dec; 49(12):2083-2090. PubMed ID: 28932911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of the Intestinal Microbiota in Diagnosing the Progression of Diabetes and the Presence of Cardiovascular Complications.
    Leustean AM; Ciocoiu M; Sava A; Costea CF; Floria M; Tarniceriu CC; Tanase DM
    J Diabetes Res; 2018; 2018():5205126. PubMed ID: 30539026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota in Adipose Tissue Dysfunction Induced Cardiovascular Disease: Role as a Metabolic Organ.
    Yang X; Zhang X; Yang W; Yu H; He Q; Xu H; Li S; Shang Z; Gao X; Wang Y; Tong Q
    Front Endocrinol (Lausanne); 2021; 12():749125. PubMed ID: 34552566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbial metabolite TMAO contributes to renal dysfunction in a mouse model of diet-induced obesity.
    Sun G; Yin Z; Liu N; Bian X; Yu R; Su X; Zhang B; Wang Y
    Biochem Biophys Res Commun; 2017 Nov; 493(2):964-970. PubMed ID: 28942145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.
    Trøseid M; Hov JR; Nestvold TK; Thoresen H; Berge RK; Svardal A; Lappegård KT
    Metab Syndr Relat Disord; 2016 May; 14(4):197-201. PubMed ID: 27081744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiota in Vascular Disease: Therapeutic Target?
    Anbazhagan AN; Priyamvada S; Priyadarshini M
    Curr Vasc Pharmacol; 2017; 15(4):291-295. PubMed ID: 28056754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiome and Precision Nutrition in Heart Failure: Hype or Hope?
    Chaikijurajai T; Tang WHW
    Curr Heart Fail Rep; 2021 Apr; 18(2):23-32. PubMed ID: 33559845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbe-targeted choline trimethylamine lyase inhibition improves obesity via rewiring of host circadian rhythms.
    Schugar RC; Gliniak CM; Osborn LJ; Massey W; Sangwan N; Horak A; Banerjee R; Orabi D; Helsley RN; Brown AL; Burrows A; Finney C; Fung KK; Allen FM; Ferguson D; Gromovsky AD; Neumann C; Cook K; McMillan A; Buffa JA; Anderson JT; Mehrabian M; Goudarzi M; Willard B; Mak TD; Armstrong AR; Swanson G; Keshavarzian A; Garcia-Garcia JC; Wang Z; Lusis AJ; Hazen SL; Brown JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of intestinal microbiota and microbial metabolites in metabolic control.
    Herrema H; IJzerman RG; Nieuwdorp M
    Diabetologia; 2017 Apr; 60(4):613-617. PubMed ID: 28013341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota and Atherosclerosis.
    Li DY; Tang WHW
    Curr Atheroscler Rep; 2017 Aug; 19(10):39. PubMed ID: 28842845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.